Submitted by Anonymous (not verified) on 1 February 2024 - 15:27
Orphan designation: Selumetinib Treatment of glioma, 13/12/2023 Positive
Source:
Orphan designation: Selumetinib Treatment of glioma, 13/12/2023 Positive